首页 › 结直肠癌 › 俄克拉荷马州 › Oklahoma City
Oklahoma City OK 结直肠癌临床试验
22项针对 结直肠癌的研究正在 Oklahoma City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- University of Oklahoma Health Sciences Center, Oklahoma City
Family Communications After Genetic Testing
招募中欢迎健康志愿者
- Mercy Hospital Oklahoma City, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- University of Oklahoma, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Mercy Hospital Oklahoma City, Oklahoma City
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
招募中1 期
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
招募中1 期
- University of Oklahoma Health Sciences Center, Oklahoma City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
招募中1/2 期
- Stephenson Cancer Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- University of Oklahoma, Oklahoma City
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
招募中1 期
- University of Oklahoma Health Sciences Center, Oklahoma City
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
招募中3 期
- Clinical Study Site, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
招募中1/2 期
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
招募中1/2 期
- University of Oklahoma Health Sciences Center, Oklahoma City
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
招募中
- TSET Health Promotion Research Center, Oklahoma City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- Stephenson Cancer Center, Oklahoma City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
招募中1/2 期
- SSM OKC Hightower Clinical, Oklahoma City
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
招募中2 期
- Hightower Clinical, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
招募中观察性研究
- Mercy Hospital - OKC, Oklahoma City
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
招募中1 期
- OU Stephenson Cancer Center, Oklahoma City
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
招募中1 期
- OU Health Stephenson Cancer Center, Oklahoma City
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
招募中3 期欢迎健康志愿者
- Mercy Hospital Oklahoma City, Oklahoma City
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Mercy Hospital Oklahoma City, Oklahoma City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
招募中观察性研究
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
其他城市的 结直肠癌试验
- Houston, TX102 项研究
- New York City, NY78 项研究
- Nashville, TN69 项研究
- Boston, MA63 项研究
- Los Angeles, CA59 项研究
- Arlington, VA52 项研究
- St. Louis, MO50 项研究
- San Antonio, TX46 项研究
- Philadelphia, PA44 项研究
- Grand Rapids, MI40 项研究
- Baldwin Park, CA37 项研究
- Chicago, IL34 项研究
Oklahoma City的其他研究
- 非小细胞肺癌28 项研究
- 卵巢癌28 项研究
- 子宫内膜癌25 项研究
- 前列腺癌21 项研究
- 肺癌19 项研究
- 乳腺癌17 项研究
- 转移性癌症16 项研究
- 癌症（所有类型）14 项研究
- 急性髓系白血病14 项研究
- 头颈鳞状细胞癌13 项研究
- 膀胱癌11 项研究
- 胰腺癌11 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。